A team of Northwestern Medicine investigators identified a specific gene as a key regulator of immune cells called invariant natural killer T cells, which may present therapeutic potential for the treatment of autoimmune diseases.
A previously unknown migration of glioblastoma may explain why current treatments stall out over time, according to a new study.
A new study has discovered previously unknown details about a mechanism that lets white blood cells travel from blood vessels into tissue, a process key to inflammation.
Interruptions in circadian rhythm protected against damage in a model of Huntington’s disease, suggesting an unexpected neuroprotective effect for mild stress to the brain from irregular patterns of sleep.
Kathleen Green, PhD, the Joseph L. Mayberry, Sr., Professor of Pathology and Toxicology and professor of Dermatology, has been named the winner for the 2019 Tripartite Legacy Faculty Prize in Translational Science and Education.
Northwestern Medicine scientists demonstrated how innate immune cells in inflamed tissue induce DNA damage that promotes the development of cancer.
Northwestern Medicine scientists have discovered a novel signaling pathway that promotes healing and tissue repair after heart attack, in a study published in Cell Metabolism.
Armed with a prestigious new grant, investigators prepare to rapidly translate scientific breakthroughs into better brain tumor therapies. Read the story in Northwestern Medicine magazine.
The Lurie Cancer Center solidifies its place among the country’s elite after extraordinary growth and a top rating from the National Cancer Institute. Read the story in Northwestern Medicine magazine.
Scientists have identified a novel regulator of liver metabolism, which could serve as a potential therapeutic target for obesity, type 2 diabetes and related conditions.